Top advances of the year: Gastroesophageal cancer
Cancer · 01.06.2026 · 132 (11)
DOI: 10.1002/cncr.70471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 29.05.2026. Verfasst von Ryan C Augustin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben.
Abstract (Originalsprache)
Recent advances in gastroesophageal cancer highlight the continued evolution of systemic therapy across disease stages, including refinements in perioperative strategies and expansion of biomarker‐directed treatment in advanced disease. Emerging therapeutic approaches, including next‐generation antibodies and combination strategies, are expected to further shape treatment selection and improve outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Ryan C Augustin, Harry H Yoon
Zitieren
APA
Augustin, R. C., Jin, Z., & Yoon, H. H. (2026). Top advances of the year: Gastroesophageal cancer. Cancer, 132(11). https://doi.org/10.1002/cncr.70471
Vancouver
Augustin RC, Jin Z, Yoon HH. Top advances of the year: Gastroesophageal cancer. Cancer. 2026;132(11). doi:10.1002/cncr.70471
BibTeX
@article{Augustin2026,
author = {Augustin, Ryan C and Jin, Zhaohui and Yoon, Harry H},
title = {Top advances of the year: Gastroesophageal cancer},
journal = {Cancer},
year = {2026},
volume = {132},
number = {11},
doi = {10.1002/cncr.70471}
}
EUVIMED